Market Overview:
The global implantable cardiac devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in implantable cardiac devices, and rising geriatric population. The global implantable cardiac devices market is segmented on the basis of type into pacemakers, ICDs, and BI-V ICDs. The pacemaker segment is expected to account for the largest share of the global implantable cardiac devices market in 2018. This can be attributed to its high adoption rate due to its ability to treat bradycardia (a heart rhythm disorder). The ICD segment is projected to grow at a higher CAGR than other segments during the forecast period owingtoits growing demand for treatment of tachycardia (a heart rhythm disorder) and heart failure.
Product Definition:
Implantable cardiac devices are medical devices that are implanted in a person's body to help treat heart problems. These devices include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Implantable cardiac devices are important because they can help people with heart problems live longer, healthier lives.
Pacemaker:
Pacemaker is a cardiac assist device that helps in maintaining the normal sinus rhythm. It is used to treat conditions such as bradycardia and tachycardia. The growth factor for pacemaker market includes various factors such as increasing geriatric population base, rising prevalence of cardiovascular diseases, technological advancements in pacemakers and implantable cardioverter defibrillators (ICD) among others.
ICD:
ICD is an electronic device which generates and displays a series of beeps, which are then converted into an electrical signal by the implantable cardiac devices. The beep pattern varies according to the severity of the heart condition. ICDs are majorly used for chronic heart failure, but they can also be used in cases of acute myocardial infarction (MI), arrhythmia or fibrillation.
Application Insights:
Based on the application, the global implantable cardiac devices market is segmented into bradycardia, tachycardia, heart failure and other. The heart failure segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high prevalence of cardiopulmonary diseases that require long-term treatment with an ICD or a pacemaker for normalization of heartbeat. According to estimates published by WHO in 2018, out of all deaths caused by Cardiovascular Diseases (CVDs), around 31% are due to Heart Failure (HF). Moreover, according to data published by CDC in 2019 regarding death certificates issued between 2015 and 2016 across various age groups and genders worldwide; it was observed that around 562 thousand people died due largely preventable causes such as smoking-related illnesses along with CVDs during this period. Thus these factors are expected to drive demand over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large patient pool, favorable reimbursement policies, and increasing awareness about advanced cardiac care facilities in this region. Moreover, high adoption of technologically advanced products is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and economic development in emerging countries like India and China. Furthermore, an increase in geriatric population coupled with lifestyle-associated diseases will further boost demand for ICDs devices over this period.
Growth Factors:
- Increasing incidence of cardiovascular diseases (CVDs)
- Growing geriatric population
- Rising demand for minimally invasive procedures
- Technological advancements in implantable cardiac devices
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Cardiac Devices Market Research Report
By Type
Pacemaker, ICD, BI-V ICD
By Application
Bradycardia, Tachycardia, Heart Failure, Other
By Companies
Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical, Cardioelectronica, CCC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Cardiac Devices Market Report Segments:
The global Implantable Cardiac Devices market is segmented on the basis of:
Types
Pacemaker, ICD, BI-V ICD
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bradycardia, Tachycardia, Heart Failure, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Abbott
- Boston Scientific
- Biotronik
- LivaNova (Sorin)
- Medico
- IMZ
- Pacetronix
- Qinming Medical
- Cardioelectronica
- CCC
Highlights of The Implantable Cardiac Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pacemaker
- ICD
- BI-V ICD
- By Application:
- Bradycardia
- Tachycardia
- Heart Failure
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Cardiac Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Implantable cardiac devices are medical devices that are placed inside the body to help treat heart conditions. These devices can include pacemakers, defibrillators, and stents.
Some of the major companies in the implantable cardiac devices market are Medtronic, Abbott, Boston Scientific, Biotronik, LivaNova (Sorin), Medico, IMZ, Pacetronix, Qinming Medical, Cardioelectronica, CCC.
The implantable cardiac devices market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Implantable Cardiac Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Implantable Cardiac Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Implantable Cardiac Devices Market - Supply Chain
4.5. Global Implantable Cardiac Devices Market Forecast
4.5.1. Implantable Cardiac Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Implantable Cardiac Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Implantable Cardiac Devices Market Absolute $ Opportunity
5. Global Implantable Cardiac Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Implantable Cardiac Devices Market Size and Volume Forecast by Type
5.3.1. Pacemaker
5.3.2. ICD
5.3.3. BI-V ICD
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Implantable Cardiac Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Implantable Cardiac Devices Market Size and Volume Forecast by Application
6.3.1. Bradycardia
6.3.2. Tachycardia
6.3.3. Heart Failure
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Implantable Cardiac Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Implantable Cardiac Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Implantable Cardiac Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Implantable Cardiac Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Implantable Cardiac Devices Demand Share Forecast, 2019-2026
9. North America Implantable Cardiac Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Implantable Cardiac Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Implantable Cardiac Devices Market Size and Volume Forecast by Application
9.4.1. Bradycardia
9.4.2. Tachycardia
9.4.3. Heart Failure
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Implantable Cardiac Devices Market Size and Volume Forecast by Type
9.7.1. Pacemaker
9.7.2. ICD
9.7.3. BI-V ICD
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Implantable Cardiac Devices Demand Share Forecast, 2019-2026
10. Latin America Implantable Cardiac Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Implantable Cardiac Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Implantable Cardiac Devices Market Size and Volume Forecast by Application
10.4.1. Bradycardia
10.4.2. Tachycardia
10.4.3. Heart Failure
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Implantable Cardiac Devices Market Size and Volume Forecast by Type
10.7.1. Pacemaker
10.7.2. ICD
10.7.3. BI-V ICD
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Implantable Cardiac Devices Demand Share Forecast, 2019-2026
11. Europe Implantable Cardiac Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Implantable Cardiac Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Implantable Cardiac Devices Market Size and Volume Forecast by Application
11.4.1. Bradycardia
11.4.2. Tachycardia
11.4.3. Heart Failure
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Implantable Cardiac Devices Market Size and Volume Forecast by Type
11.7.1. Pacemaker
11.7.2. ICD
11.7.3. BI-V ICD
11.8. Bass Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Implantable Cardiac Devices Demand Share, 2019-2026
12. Asia Pacific Implantable Cardiac Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Implantable Cardiac Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Implantable Cardiac Devices Market Size and Volume Forecast by Application
12.4.1. Bradycardia
12.4.2. Tachycardia
12.4.3. Heart Failure
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Implantable Cardiac Devices Market Size and Volume Forecast by Type
12.7.1. Pacemaker
12.7.2. ICD
12.7.3. BI-V ICD
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Implantable Cardiac Devices Demand Share, 2019-2026
13. Middle East & Africa Implantable Cardiac Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Implantable Cardiac Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Implantable Cardiac Devices Market Size and Volume Forecast by Application
13.4.1. Bradycardia
13.4.2. Tachycardia
13.4.3. Heart Failure
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Implantable Cardiac Devices Market Size and Volume Forecast by Type
13.7.1. Pacemaker
13.7.2. ICD
13.7.3. BI-V ICD
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Implantable Cardiac Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Implantable Cardiac Devices Market: Market Share Analysis
14.2. Implantable Cardiac Devices Distributors and Customers
14.3. Implantable Cardiac Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biotronik
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. LivaNova (Sorin)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Medico
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. IMZ
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Pacetronix
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Qinming Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cardioelectronica
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. CCC
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
